Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity.
Gutjahr JC, Bayer E, Yu X, Laufer JM, Höpner JP, Tesanovic S, Härzschel A, Auer G, Rieß T, Salmhofer A, Szenes E, Haslauer T, Durand-Onayli V, Ramspacher A, Pennisi SP, Artinger M, Zaborsky N, Chigaev A, Aberger F, Neureiter D, Pleyer L, Legler DF, Orian-Rousseau V, Greil R, Hartmann TN. Gutjahr JC, et al. Among authors: tesanovic s. Haematologica. 2021 Aug 1;106(8):2102-2113. doi: 10.3324/haematol.2019.231944. Haematologica. 2021. PMID: 32616529 Free PMC article.
Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance.
Gruber W, Peer E, Elmer DP, Sternberg C, Tesanovic S, Del Burgo P, Coni S, Canettieri G, Neureiter D, Bartz R, Kohlhof H, Vitt D, Aberger F. Gruber W, et al. Among authors: tesanovic s. Int J Cancer. 2018 Mar 1;142(5):968-975. doi: 10.1002/ijc.31117. Epub 2017 Nov 6. Int J Cancer. 2018. PMID: 29055107 Free PMC article.
Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
Sternberg C, Gruber W, Eberl M, Tesanovic S, Stadler M, Elmer DP, Schlederer M, Grund S, Roos S, Wolff F, Kaur S, Mangelberger D, Lehrach H, Hache H, Wierling C, Laimer J, Lackner P, Wiederstein M, Kasper M, Risch A, Petzelbauer P, Moriggl R, Kenner L, Aberger F. Sternberg C, et al. Among authors: tesanovic s. Int J Cancer. 2018 Dec 1;143(11):2943-2954. doi: 10.1002/ijc.31724. Epub 2018 Oct 1. Int J Cancer. 2018. PMID: 29987839 Free PMC article.
Effect of Athena SWAN funding incentives on women's research leadership.
Ovseiko PV, Taylor M, Gilligan RE, Birks J, Elhussein L, Rogers M, Tesanovic S, Hernandez J, Wells G, Greenhalgh T, Buchan AM. Ovseiko PV, et al. Among authors: tesanovic s. BMJ. 2020 Oct 26;371:m3975. doi: 10.1136/bmj.m3975. BMJ. 2020. PMID: 33106283 No abstract available.
[CROATIAN GUIDELINES FOR THE PHARMACOTHERAPY OF TYPE 2 DIABETES].
Rahelić D, Altabas V, Bakula M, Balić S, Balint I, Marković BB, Bicanić N, Bjelinski I, Bozikov V, Varzić SC, Car N, Berković MC, Orlić ZC, Deskin M, Sunić ED, Tomić NG, Goldoni V, Gradiser M, Mahecić DH, Balen MJ, Erzen DJ, Majanović SK, Kokić' S, Krnic M, Kruljac I, Liberati-Cizmek AM, Martina L, Metelko Z, Mirosević G, Vrbica SM, Renar IP, Petric D, Prasek M, Prpić-Kizevać I, Radman M, Soldo D, Sarić T, Tesanović S, Kurir TT, Wensveen TT, Botica M, Vrkljan M, Rotkvic VZ, Zorić C, Krznarić Z. Rahelić D, et al. Among authors: tesanovic s. Lijec Vjesn. 2016 Jan-Feb;138(1-2):1-21. Lijec Vjesn. 2016. PMID: 27443001 Croatian.
17 results